Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2021-11-02 00:00:00 ET · period of report 2021-08-16 · accession 0000950142-21-003503 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-02 | 2021-08-16 | NRXP | Besthof Robert | Chief Comm, Patient Off | M - OptEx | $0.2 | +63.7K | 63.7K | New | +$12.7K |
| D | 2021-11-02 | 2021-09-15 | NRXP | Besthof Robert | Chief Comm, Patient Off | S - Sale+OE | $11.76 | -40.0K | 23.7K | -63% | -$470.4K |
| D | 2021-11-02 | 2021-08-16 | NRXP | Besthof Robert | Chief Comm, Patient Off | A - Grant | $0.00 | +36.3K | 36.3K | New | $0 |
| D | 2021-11-02 | 2021-08-16 | NRXP | Besthof Robert | Chief Comm, Patient Off | C - Cnv Deriv | $0.2 | -100.0K | 247.2K | -29% | -$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | M | A | 63,710 | $0.2 | 63,710 | D | — | — | (F1) The options are fully vested. |
| 2 | Common | Common Stock | 2021-09-15 | S | D | 40,000 | $11.76 | 23,710 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-08-16 | A | A | 36,290 | $0.00 | 36,290 | D | — · — to — | 36,290 Common Stock | (F2) Shares and restricted stock units acquired pursuant to the exercise of 100,000 vested stock options under the NRX Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan (the "Plan"). The Reporting person received 63,701 freely tradable shares of common stock, par value $0.001 per share, of NRX Pharmaceuticals, Inc. (the "Common Stock") and 36,290 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock. The restricted stock units remain in the Plan and are subject to forfeiture if the Earnout Share Milestone and the Earnout Cash Milestone (as defined in the Merger Agreement) do not occur on or prior to December 31, 2022. |
| 4 | Derivative | Employee Stock Option (Right to buy) | 2021-08-16 | C | D | 100,000 | $0.2 | 247,200 | D | $0.2 · — to 2026-03-01 | 100,000 Common Stock | (F1) The options are fully vested. |